• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中度至高度的5年累积疾病活动度及较低的股骨近端骨密度是长期类风湿关节炎女性脆性骨折的主要预测因素:一项观察性队列研究

Moderate-to-High 5-Year Cumulative Disease Activity and Lower Bone Mineral Density at the Proximal Femur are Major Predictors of Fragility Fractures in Women with Longstanding Rheumatoid Arthritis: An Observational Cohort Study.

作者信息

Ramos Fernanda P, Pinheiro Marcela M C, Silva Luiza V A, Viner Eliana P C, Szejnfeld Vera L, Castro Charlles H M

机构信息

Rheumatology Division, Escola Paulista de Medicina/Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, Brazil.

Escola Paulista de Medicina/Universidade Federal de São Paulo (EPM/UNIFESP), Rua dos Otonis, 863. Vila Clementino, São Paulo, CEP, 04025-002, Brazil.

出版信息

Calcif Tissue Int. 2025 Aug 25;116(1):113. doi: 10.1007/s00223-025-01419-0.

DOI:10.1007/s00223-025-01419-0
PMID:40855385
Abstract

Rheumatoid arthritis (RA) has a higher risk of fractures that is often neglected. We determined the prevalence and risk factors for fractures in women with longstanding RA. Consecutive women with RA from a tertiary hospital underwent bone densitometry (DXA) and spine radiography with morphometric analysis. Disease characteristics, activity, and medication use were assessed. Logistic and linear regression analyses identified risk factors for osteoporosis and fractures. The study included 179 women with RA aged 65.1 ± 9.7 years with a median disease duration of 21 (12.5) years (72% positive for rheumatoid factor). Glucocorticoid (GC), csDMARDs, b/tsDMARDs use, and current moderate-to-high disease activity were observed in 26.3%, 92.7%, 58.6%, and 45.3% of the patients, respectively. Densitometric osteoporosis and fractures were found in 43.6% and 28.5% of the patients, respectively. Fractures were observed in 51 patients (28.5%), primarily occurring at the spine (N = 43) and forearm (N = 10). Almost half of the patients with fractures (N = 24) had a BMD T-score greater than - 2.5. BMI (OR 0.916; 95%CI 0.854-0.983; P = 0.015) and smoking load (OR 1.023; 95%CI 1.002-1.044; P = 0.032) were predictors for osteoporosis, while cumulative 5-year disease activity (OR 3.474; 95%CI 1.557-7.751; P = 0.002) and total femur T-score (OR 0.646; 95%CI 0.436-0.956; P = 0.029) were predictors of fractures. Current GC dose and femoral neck T-score were predictors of spinal deformity index (R = 0.108; P < 0.001). Almost half of the women with longstanding RA presenting with fractures had BMD values above the osteoporotic range. Moderate-to-high cumulative 5-year disease activity, GC use, and lower BMD at the proximal femur were risk factors for fractures.

摘要

类风湿关节炎(RA)患者发生骨折的风险较高,这一点常常被忽视。我们确定了长期患RA女性骨折的患病率及风险因素。来自一家三级医院的连续的RA女性患者接受了骨密度测定(DXA)以及脊柱X线摄影和形态计量分析。评估了疾病特征、活动情况及用药情况。逻辑回归和线性回归分析确定了骨质疏松症和骨折的风险因素。该研究纳入了179名年龄为65.1±9.7岁、中位病程为21(12.5)年的RA女性患者(72%类风湿因子阳性)。分别有26.3%、92.7%、58.6%和45.3%的患者使用糖皮质激素(GC)、传统合成改善病情抗风湿药(csDMARDs)、生物制剂或靶向合成改善病情抗风湿药(b/tsDMARDs)以及目前疾病活动度为中度至高度。分别有43.6%和28.5%的患者存在骨密度测定骨质疏松症和骨折。51名患者(28.5%)发生了骨折,主要发生在脊柱(n = 43)和前臂(n = 10)。几乎一半发生骨折的患者(n = 24)骨密度T值大于 - 2.5。体重指数(OR 0.916;95%CI 0.854 - 0.983;P = 0.015)和吸烟量(OR 1.023;95%CI 1.002 - 1.044;P = 0.032)是骨质疏松症的预测因素,而累积5年疾病活动度(OR 3.474;95%CI 1.557 - 7.751;P = 0.002)和股骨总T值(OR 0.646;95%CI 0.436 - 0.956;P = 0.029)是骨折的预测因素。目前的GC剂量和股骨颈T值是脊柱畸形指数的预测因素(R = 0.108;P < 0.001)。几乎一半发生骨折的长期患RA女性患者的骨密度值高于骨质疏松范围。累积5年中度至高度疾病活动度、使用GC以及股骨近端较低的骨密度是骨折的风险因素。

相似文献

1
Moderate-to-High 5-Year Cumulative Disease Activity and Lower Bone Mineral Density at the Proximal Femur are Major Predictors of Fragility Fractures in Women with Longstanding Rheumatoid Arthritis: An Observational Cohort Study.中度至高度的5年累积疾病活动度及较低的股骨近端骨密度是长期类风湿关节炎女性脆性骨折的主要预测因素:一项观察性队列研究
Calcif Tissue Int. 2025 Aug 25;116(1):113. doi: 10.1007/s00223-025-01419-0.
2
Geriatric nutritional risk index as a predictor for fragility fracture risk in elderly with type 2 diabetes mellitus: A 9-year ambispective longitudinal cohort study.老年营养风险指数作为2型糖尿病老年人脆性骨折风险的预测指标:一项9年的双向纵向队列研究
Clin Nutr. 2024 May;43(5):1125-1135. doi: 10.1016/j.clnu.2024.03.032. Epub 2024 Apr 1.
3
Age at First Fracture and Later Fracture Risk in Older Adults Undergoing Osteoporosis Assessment.接受骨质疏松症评估的老年人首次骨折年龄与后期骨折风险
JAMA Netw Open. 2024 Dec 2;7(12):e2448208. doi: 10.1001/jamanetworkopen.2024.48208.
4
A systematic review of the effectiveness of strategies for reducing fracture risk in children with juvenile idiopathic arthritis with additional data on long-term risk of fracture and cost of disease management.对降低幼年特发性关节炎患儿骨折风险策略的有效性进行系统评价,并提供关于骨折长期风险和疾病管理成本的额外数据。
Health Technol Assess. 2008 Mar;12(3):iii-ix, xi-xiv, 1-208. doi: 10.3310/hta12030.
5
New Challenges: Use and Interpretation of Radius Bone Mineral Density.新挑战:桡骨骨密度的应用与解读
J Clin Endocrinol Metab. 2024 Dec 18;110(1):e1-e7. doi: 10.1210/clinem/dgae726.
6
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.利塞膦酸钠用于绝经后妇女骨质疏松性骨折的一级和二级预防。
Cochrane Database Syst Rev. 2022 May 3;5(5):CD004523. doi: 10.1002/14651858.CD004523.pub4.
7
Treatment for osteoporosis in people with ß-thalassaemia.β地中海贫血患者骨质疏松症的治疗
Cochrane Database Syst Rev. 2016 Mar 10;3:CD010429. doi: 10.1002/14651858.CD010429.pub2.
8
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.糖皮质激素性骨质疏松症:一项系统评价与成本效用分析
Health Technol Assess. 2007 Mar;11(7):iii-iv, ix-xi, 1-231. doi: 10.3310/hta11070.
9
Associations between ultra-distal forearm bone mineral density and incident fracture in women.女性超远端前臂骨密度与骨折事件的相关性。
Osteoporos Int. 2024 Jun;35(6):1019-1027. doi: 10.1007/s00198-024-07041-4. Epub 2024 Mar 6.
10
Calcium and vitamin D for increasing bone mineral density in premenopausal women.钙和维生素 D 增加绝经前妇女的骨密度。
Cochrane Database Syst Rev. 2023 Jan 27;1(1):CD012664. doi: 10.1002/14651858.CD012664.pub2.

本文引用的文献

1
2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.2022 年美国风湿病学会糖皮质激素诱导性骨质疏松症预防和治疗指南。
Arthritis Rheumatol. 2023 Dec;75(12):2088-2102. doi: 10.1002/art.42646. Epub 2023 Oct 16.
2
Risk factors for osteoporosis and fractures in rheumatoid arthritis.类风湿关节炎中骨质疏松和骨折的危险因素。
Best Pract Res Clin Rheumatol. 2022 Sep;36(3):101773. doi: 10.1016/j.berh.2022.101773. Epub 2022 Oct 5.
3
The Effect of Anti-rheumatic Drugs on the Skeleton.
抗风湿药物对骨骼的影响。
Calcif Tissue Int. 2022 Nov;111(5):445-456. doi: 10.1007/s00223-022-01001-y. Epub 2022 Jun 30.
4
Impact of biologic disease-modifying antirheumatic drugs on fracture risk in patients with rheumatoid arthritis: a systematic review and meta-analysis.生物制剂类改善病情抗风湿药物对类风湿关节炎患者骨折风险的影响:系统评价和荟萃分析。
Eur Rev Med Pharmacol Sci. 2021 May;25(9):3416-3424. doi: 10.26355/eurrev_202105_25821.
5
Time-averaged disease activity of rheumatoid arthritis associated with long-term bone mineral density changes.类风湿关节炎的时间平均疾病活动度与长期骨密度变化的关系
Ther Adv Chronic Dis. 2020 Dec 23;11:2040622320981517. doi: 10.1177/2040622320981517. eCollection 2020.
6
Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis.类风湿关节炎患者骨密度与自身抗体的相关性。
Arthritis Rheumatol. 2021 Jun;73(6):921-930. doi: 10.1002/art.41623. Epub 2021 May 10.
7
Bone Loss, Osteoporosis, and Fractures in Patients with Rheumatoid Arthritis: A Review.类风湿关节炎患者的骨质流失、骨质疏松症和骨折:综述
J Clin Med. 2020 Oct 20;9(10):3361. doi: 10.3390/jcm9103361.
8
EULAR definition of difficult-to-treat rheumatoid arthritis.EULAR 定义的难治性类风湿关节炎。
Ann Rheum Dis. 2021 Jan;80(1):31-35. doi: 10.1136/annrheumdis-2020-217344. Epub 2020 Oct 1.
9
Rheumatoid arthritis in tight disease control is no longer risk of bone mineral density loss.严格疾病控制下的类风湿关节炎不再有骨密度丧失的风险。
Osteoporos Sarcopenia. 2020 Jun;6(2):75-81. doi: 10.1016/j.afos.2020.04.002. Epub 2020 Jun 4.
10
Comparative risk of osteoporotic fracture among patients with rheumatoid arthritis receiving TNF inhibitors versus other biologics: a cohort study.类风湿关节炎患者接受 TNF 抑制剂与其他生物制剂治疗后的骨质疏松性骨折风险比较:一项队列研究。
Osteoporos Int. 2020 Nov;31(11):2131-2139. doi: 10.1007/s00198-020-05488-9. Epub 2020 Jun 8.